Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:ASLNASDAQ:AURACVE:DAUCVE:EASCVE:XAG Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASLArgentum SilverC$0.04-11.1%C$0.03C$0.03▼C$0.07C$2.06M1.7111,262 shs20,000 shsAURAAura Biosciences$7.10-1.7%$8.01$5.99▼$13.50$351.45M0.36169,804 shs87,949 shsDAUDesert Gold VenturesC$0.06-7.7%C$0.07C$0.03▼C$0.10C$11.73M1.7172,828 shs310,000 shsEASBaru Gold Corp. (EAS.V)C$0.16-3.1%C$0.16C$0.02▼C$0.24C$22.97MN/A345,802 shs136,956 shsXAGXtierraC$0.03-28.6%C$0.02C$0.02▼C$0.07C$4.89M0.8836,989 shs7,000 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASLArgentum Silver0.00%-11.11%+33.33%+60.00%0.00%AURAAura Biosciences-1.66%+1.00%-10.13%-6.21%-21.55%DAUDesert Gold Ventures-7.69%-14.29%-14.29%+71.43%+33.33%EASBaru Gold Corp. (EAS.V)0.00%0.00%0.00%0.00%0.00%XAGXtierra0.00%0.00%0.00%0.00%0.00%top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASLArgentum SilverN/AN/AN/AN/AN/AN/AN/AN/AAURAAura Biosciences1.4461 of 5 stars3.50.00.00.02.91.70.6DAUDesert Gold VenturesN/AN/AN/AN/AN/AN/AN/AN/AEASBaru Gold Corp. (EAS.V)N/AN/AN/AN/AN/AN/AN/AN/AXAGXtierraN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASLArgentum SilverN/AN/AN/AN/AAURAAura Biosciences3.00Buy$21.00195.77% UpsideDAUDesert Gold VenturesN/AN/AN/AN/AEASBaru Gold Corp. (EAS.V)N/AN/AN/AN/AXAGXtierraN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASLArgentum SilverN/AN/AC$0.01 per share3.16N/AN/AAURAAura BiosciencesN/AN/AN/AN/A$4.58 per shareN/ADAUDesert Gold VenturesN/AN/AC$0.00 per share60.00N/AN/AEASBaru Gold Corp. (EAS.V)N/AN/AC$0.00 per share60.00C$0.00 per shareN/AXAGXtierraN/AN/AC$0.00 per share50.00C($0.01) per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASLArgentum SilverN/A-C$0.01N/A∞N/AN/A-88.18%-37.68%5/24/2024 (Estimated)AURAAura Biosciences-$76.41M-$1.92N/AN/AN/AN/A-42.20%-36.66%5/9/2024 (Estimated)DAUDesert Gold Ventures-C$1.27M-C$0.01N/A∞N/AN/A-3,951.95%-180.42%6/4/2024 (Estimated)EASBaru Gold Corp. (EAS.V)N/A-C$0.01N/A∞N/AN/AN/AN/AN/AXAGXtierraN/AN/AN/A∞N/AN/AN/A-3.18%N/ALatest XAG, ASL, EAS, DAU, and AURA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2024Q4 2023AURAAura Biosciences-$0.39-$0.50-$0.11-$0.50N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASLArgentum SilverN/AN/AN/AN/AN/AAURAAura BiosciencesN/AN/AN/AN/AN/ADAUDesert Gold VenturesN/AN/AN/AN/AN/AEASBaru Gold Corp. (EAS.V)N/AN/AN/AN/AN/AXAGXtierraN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASLArgentum SilverN/A5.8314.02AURAAura BiosciencesN/A18.7618.76DAUDesert Gold Ventures124.812.390.54EASBaru Gold Corp. (EAS.V)N/A0.080.02XAGXtierraN/AN/A0.00OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASLArgentum SilverN/AAURAAura Biosciences96.75%DAUDesert Gold Ventures7.85%EASBaru Gold Corp. (EAS.V)N/AXAGXtierraN/AInsider OwnershipCompanyInsider OwnershipASLArgentum Silver62.18%AURAAura Biosciences5.90%DAUDesert Gold Ventures4.85%EASBaru Gold Corp. (EAS.V)N/AXAGXtierra38.93%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableASLArgentum SilverN/A51.60 millionN/ANot OptionableAURAAura Biosciences8849.50 million46.58 millionNot OptionableDAUDesert Gold VenturesN/A195.47 millionN/ANot OptionableEASBaru Gold Corp. (EAS.V)N/A148.21 millionN/ANot OptionableXAGXtierraN/A195.69 millionN/ANot OptionableXAG, ASL, EAS, DAU, and AURA HeadlinesSourceHeadlineXAG/SAR - Silver Spot Saudi Riyalinvesting.com - April 20 at 12:31 PMUS Dollar Index News: Fed’s Cautious Tone Bolsters DXY’s Short-Term Prospectsfxempire.com - April 19 at 9:23 PMSilver Prices Forecast: Traders Eyeing Psychological Target at $30fxempire.com - April 11 at 3:29 PMXAG/PKR - Silver Spot Pakistani Rupeeinvesting.com - April 10 at 6:35 PMXPD/XAG - Palladium Spot Silver Spotinvesting.com - April 5 at 10:55 PMXAG/ILS - Silver Spot Israeli Shekelinvesting.com - April 1 at 9:44 PMDaily Silver Price in Europe • Silver Price in Euro • XAG in EURprokerala.com - March 31 at 2:04 PMDaily Silver Price in Kuwait • Silver Price in Kuwaiti Dinar • XAG in KWDprokerala.com - March 27 at 10:09 AMSilver Prices Forecast: How Will Fed’s Rate Decision Impact XAG/USD Momentum?fxempire.com - March 27 at 10:09 AMSilver Prices Forecast: Fed Policy, Global Central Banks Set to Propel XAG/USDfxempire.com - March 22 at 6:25 AMXAG/QAR - Silver Spot Qatari Riyalinvesting.com - March 16 at 7:19 PMSilver Prices Forecast: XAG/USD Grapples with Dollar Might and Rate Uncertaintiesfxempire.com - March 15 at 1:16 AMDaily Silver Price in Bahrain • Silver Price in Bahraini Dinar • XAG in BHDprokerala.com - February 27 at 3:02 PMSilver Price Analysis: XAG/USD rallies amid risk-on mood, low US yieldsfxstreet.com - February 26 at 12:36 AMXPT/XAG - Platinum Spot Silver Spotinvesting.com - January 24 at 2:22 AMConvert New Zealand Dollar To Silver Ounceforbes.com - January 3 at 9:47 AMSilver lurches higher as markets wrap up 2023, XAG/USD rebounds from $24.00fxstreet.com - December 29 at 10:34 PMConvert Silver Ounce To Iraqi Dinarforbes.com - December 1 at 1:45 PMXAG/USD: Technical Analysisinvesting.com - November 30 at 4:17 PMXAG/RUB Technical Analysisinvesting.com - November 10 at 6:51 PMConvert Hungarian Forint To Silver Ounceforbes.com - November 2 at 8:54 AMConvert Swedish Krona To Silver Ounceforbes.com - October 30 at 9:53 PMSilver Spot Multi-Contributorreuters.com - October 8 at 1:45 PMConvert Swiss Franc To Silver Ounceforbes.com - September 25 at 9:58 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines5 Cheap Dividend Stocks: Which to Buy NowApril 1, 2024 9:55 AMView 5 Cheap Dividend Stocks: Which to Buy NowPVH Stock Gets 25% Discount: Is Now the Time to Buy?April 2, 2024 11:25 AMView PVH Stock Gets 25% Discount: Is Now the Time to Buy?ASML’s Earnings Could Bring The Stock to New HighsApril 16, 2024 10:20 AMView ASML’s Earnings Could Bring The Stock to New Highs3 Energy Stocks to Consider as the Sector Breaks OutApril 8, 2024 8:55 AMView 3 Energy Stocks to Consider as the Sector Breaks OutUnusually High Volume Points to Upside in These StocksApril 5, 2024 7:45 AMView Unusually High Volume Points to Upside in These StocksAll Headlines Company DescriptionsArgentum SilverCVE:ASLArgentum Silver Corp., a junior mineral exploration company, engages in the acquisition, exploration, evaluation, and development of mineral properties in Canada and Peru. It holds 100% interest in the Cochavara silver-lead-zinc project comprising six concessions covering an area of approximately 3,479 hectares located in La Libertad, northern Peru. The company was formerly known as Silex Ventures Ltd. and changed its name to Argentum Silver Corp. in February 2011. Argentum Silver Corp. was incorporated in 2007 and is headquartered in Toronto, Canada. Argentum Silver Corp. operates as a subsidiary of Sprott Mining Inc.Aura BiosciencesNASDAQ:AURAAura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.Desert Gold VenturesCVE:DAUDesert Gold Ventures Inc., an exploration stage company, engages in the acquisition, exploration, and development of mineral resource properties in Mali. The company primarily explores for gold ores. Its flagship project is the Senegal Mali Shear Zone project located in Western Mali. Desert Gold Ventures Inc. was incorporated in 2003 and is headquartered in Surrey, Canada.Baru Gold Corp. (EAS.V)CVE:EASEast Asia Minerals Corporation engages in the exploration and development of mineral properties in Indonesia. It holds 70% interest in Sangihe gold-copper project, which is located on the island of Sangihe covering an area of 42,000 hectares; and the Miwah gold project that consists of three contiguous exploration mining business permits covering 30,000 hectares located southeast of Banda Aceh in Aceh Province. The company is headquartered in Vancouver, Canada.XtierraCVE:XAGXtierra Inc., a natural resource company, engages in the exploration and development of precious and base metal deposits in Mexico. It primarily explores for zinc, silver, lead, copper, gold, and mercury deposits. The company holds 100% interest in the Bilbao project located to the northwest of Mexico City in the southeastern part of the State of Zacatecas; and the Laguna silver-gold-mercury project. Xtierra Inc. is headquartered in Toronto, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.